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Tennessee; and §Zhou Pei-Yuan Center for Applied Mathematics, Tsinghua University, Beijing, ChinaABSTRACT Many human neurodegenerative diseases are associated with the aggregation of insoluble amyloid-like fibrous
proteins. However, the processes by which the randomly diffusedmonomer peptides aggregate into the highly regulated amyloid
fibril structures are largely unknown. We proposed a residue-level coarse-grained variational model for the investigation of the
aggregation pathway for a small assembly of amyloid proteins, the peptide GNNQQNY from yeast prion protein Sup35. By
examining the free energy surface, we identified the residue-level sequential pathways for double parallel and antiparallel
b-peptides, which show that the central dry polar zipper structure is the major folding core in both cases. The critical nucleus
size is determined to be three peptides for the homogeneous nucleation process, whereas the zig-zag growth pattern appears
most favorably for heterogeneous nucleation. Consistent with the dock-and-lock mechanism, the aggregation process of free
peptides to the fibril core was found to be highly cooperative. The quantitative validation with the computational simulations
and experimental data demonstrated the usefulness of the proposed model in understanding the general mechanism of the
amyloid fibril system.INTRODUCTIONThe abnormal accumulation of amyloid proteins in tissues
and organs can result in the occurrence of more than 20
different neurodegenerative and nonneuropathic disorder
diseases, including Alzheimer’s disease, Parkinson’s
disease, type II diabetes, and transmissible spongiform
encephalopathies (1). Despite the significant efforts on the
investigation of the diseases, there has been no effective
treatment for preventing or even slowing down the progress
of amyloidoses (2,3). Recently, two most promising treat-
ments for the Alzheimer’s disease, latrepirdine (Dimebon;
Pfizer, Groton, CT) and tarenflurbil (Flurizan; Myriad
Genetics, Salt Lake City, UT), turned out to be ineffective
in phase-3 trials (4). As a key toward the improvement of
the pathology of amyloid-related diseases, a better under-
standing of the detailed mechanisms of amyloid fibrillo-
genesis is urgently needed.
To explore the mechanisms of amyloid fiber formation,
enormous efforts have been made from the experimental,
computational, and theoretical aspects. Among these
studies, theoretical approach has its unique advantage in
providing quantitative analytical results and explicit insights
into the mechanisms of amyloid fiber formation. For
instance, Jarrett and Lansbury (5) proposed a nucleation-
dependent polymerization model that distinctly character-
ized the lag time, critical concentration, and seeding of
amyloid aggregation. Watzky et al. (6) and Morris et al. (7)Submitted September 16, 2011, and accepted for publication December 21,
2011.
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0006-3495/12/02/0597/9 $2.00developed a two-step kinetic model and showed that a wide
range of amyloid aggregations can be fit with the minimal-
istic model of nucleation and autocatalytic growth. Knowles
et al. (8) demonstrated that general features of fibril aggre-
gation procedures, including nucleation, elongation, and
fragmentation, can be well described by the analytical solu-
tion of the master equation of the time evolution of filament
concentration.
Hong et al. (9) recently proposed a more comprehensive
mathematical dissection of the kinetic procedure of amyloid
fiber formation and a tentative classification of amyloid
proteins based on their characteristic scaling exponents.
The authors also developed a simple lattice-gas model to
explore basic statistical properties of the amyloid fiber
system (10). However, most theoretical approaches were
based on a macroscopic description of the amyloid fiber
formation procedure, which deals with the statistical
average of massive fibrils rather than individual peptide or
a small assembly of peptides. As a consequence, they cannot
provide detailed molecular-level insights into the aggre-
gation intermediates and pathways of oligomers and
protofibrils, which are believed to be a key to understanding
the origin of amyloidoses and the toxicity of amyloid
proteins (11,12).
To address these issues, in this article we propose a varia-
tional model to investigate the aggregation pathway of
amyloid fibrils at a residue-level resolution. The theoretical
framework of this model was first introduced by Portman
et al. (13–15) for the study of the protein folding problem,
which demonstrated its usefulness in constructing the free
energy surface of globular proteins (13–17). Later, Qi and
Portman (18) implemented the model in the calculation ofdoi: 10.1016/j.bpj.2011.12.036
598 Qi et al.protein folding rates and the classification of folding
patterns of two-state proteins (19). The essence of the vari-
ational model is to determine the folding pathway from
unfolded to folded states by varying the constraints on
each residue from small to large number, continuously.
Analogous to protein folding, the aggregation process of
amyloid proteins can be considered as a transition between
two distinguished states (the denatured state with amyloid
proteins randomly diffused in the solution and the
condensed state with amyloid proteins regularly packed
into fibrils). This can be explicitly characterized through
the fluctuation magnitude of each residue according to its
average position (in the denatured state, the residue fluctua-
tion is large; whereas in the condensed state, it is relatively
small), and thus by the conjugated residue constraints (in
other words, we choose the constraint parameters on each
residue as the reaction coordinates). This argument builds
up the theoretical foundation for using the variational model
to calculate the free energy surface of amyloid fibrils,
by which the aggregation pathway can be determined
from the kinetics of residue contact formation. Conceptually
in the variational model, for each state we are dealing with
the statistical average of an ensemble of structures rather
than single unique conformation. These structures may
share substantial diversity, but they are characterized
through the same residue constraints and thus can convert
into each other within the given residue fluctuations.
Here, we choose a small fibril assembly (hexamer in this
case) of the peptide GNNQQNY from the yeast prion
protein Sup35 as the model system, whose crystal structure
was recently solved by Nelson et al. (20), as shown in Fig. 1.
A typical cross-b spine structure with this short peptide may
share common characteristics of amyloid fibers, making it
an ideal model system to study the general mechanism
involved in fibril aggregations. Plenty of numerical andFIGURE 1 Typical crystal structure of hexamer made up by the peptide
GNNQQNY. The b-strands are oriented perpendicular to the fibril axis
(dashed line). The distance between two neighbor strands in the parallel
b-sheet is 4.78 A˚, and the distance between two antiparallel b-strands is
8.7 A˚. The index for each peptide is enumerated as S1, S2, S3, S4, S5,
and S6.
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also facilitate the examination of our model calculations
by the comparison with the existing data.METHODS
We first briefly outline the general variational theory for a single peptide
chain (14,15). An extension to the multiple chains, which is correlated to
amyloid fibril systems, is then described.Variational model for single peptide
In a residue-level coarse-grained variational model, single polypeptide is
specified by a collection of Ca atoms along the sequence. The Hamiltonian
of the peptide (HS) is constituted by two parts:
Hs ¼ Hchain þ Hintra: (1)
The Hchain represents the backbone potential of a collapsed polymeric
chain,
bHchain ¼ 3
2a2
X
ij
~ri$G
S
ij $~rj þ
3
2a2
B
X
i
~ri
2; (2)
where~ri represents the coordinate vector of i
th Ca atom, b ¼ 1/(kBT) is the
Boltzmann factor, a ¼ 3.8 A˚ is the average distance between two adjacent
Ca atoms, and B is conjugated to the radius of gyration of the chain and
controls the collapse degree of the polypeptide chain through a confining
harmonic potential. We set B ¼ 103 as in Portman et al. (14). The position
correlation matrix
Gs ¼ 1 g
1þ gK
R þ g
1 g2

KR
2 g2
1 g2 D (3)
is obtained through the freely rotating chain model with stiffness g¼ cos(q)
for a fixed angle q between adjacent covalent bonds. KR is the Rouse matrix
for the nearest-neighbor harmonic chain, and D represents the effect of
chain boundaries.
The interactions between nonlocal residues (Hintra) are modeled by
a summation of pairwise potentials between contact residues,
Hintra ¼
X
ij
εiju
~ri ~rj; (4)
where εij is the strength of contact interaction, depending on the chemical
natures of residues i and j, which we choose as Miyazawa-Jernigan energy
parameters in the unit of kBT (25). The pairwise contact potential can be
further approximated by a sum of three Gaussian terms,
uðrÞ ¼
X
k ¼ ðs; i; l Þ
gk exp

 3
2a2
akr
2

; (5)
where parameters gk and ak represent the strengths and ranges of short-,
intermediate-, and long-range interactions respectively. Here we set
(as, gs; ai, gi; al, gl) ¼ (3, 25; 0.54, 9; 0.27, 6) according to Portman
et al. (14), which produces a Lennard-Jones like potential with the normal-
ized minimum at r0 ¼ 6.3 A˚ (see Fig. 2).
To calculate the partition function, a reference Hamiltonian is introduced
in the variational model to approximate the native free energy surface
around the reference state by a harmonic potential well, which is written as
FIGURE 2 Pairwise residue-residue contact potential as a function of
residue distance. (Dashed line) Short-range repulsive interaction; (dotted
line) intermediate-range interaction; (dash-dotted line) long-range attrac-
tive interaction; (solid line) total contact potential. (Inset) Zoomed-in
potential well.
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; (6)
where f~rNi g is the position of the ith Ca atom in the native structure. The
value Ci represents the strength of the harmonic constraint, which is conju-gated to the fluctuation of ith residue.
Now the variational free energy surface of single peptide can be param-
eterized through the constraint parameters {Ci} as
F½fCig ¼ E TS ¼ kBT ln Z0 þ hHS  H0i0; (7)
with Z0 ¼ Tr½ebH0  being the partition function of the reference Hamilto-
nian, and h/i ¼ Tr½.ebH0 =Z0 denoting the statistical average taken0
with respect to H0.
Substituting the expressions for HS and H0 gives the variational energy
E½fCig¼
P
ij
εij
D
u
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and entropy
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E
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whereGSij ¼

d~ri$d~rj

0
a2
¼ GS þ B$I þ C1
ij
is the covariance matrix for the thermal fluctuation of residues.
dGSij ¼ GSii þ GSjj  2GSij provides the relative displacement of residue fluc-
tuations, and~si ¼ h~rii0 ¼
P
iG
S
ijCjr
N
j describes the average position of i
th
Ca atom in the reference chain.Variational model for multiple chains
For a fibril system constituted by multiple amyloid peptides, the total
Hamiltonian involves three parts: in addition to the backbone interaction
and intrachain interaction within a single peptide, the interchain interaction
between different peptides should also be taken into consideration (10), i.e.,
HM ¼
X
i
	
Hichain þ Hiintra

þX
is j
Hijinter; (10)
where Hichain and H
i
intra represent the backbone potential and the intrachain
interaction for ith peptide, and Hijinter represents the interchain interactionbetween peptide i and peptide j.
Analogous to the intrachain interaction, the interchain interaction could
be approximated by a summation of pairwise potentials between two
different residues in two different peptides, i.e.,
Hijinter ¼
hX
pq
εpqu
	~rp ~rq
iij
¼
 X
pq
εpq
X
k ¼ ðs ; i ; l Þ
gk exp

 3
2a2
ak
	
~rp ~rq

2!ij
;
(11)
where index p denotes the pth residue in peptide i, and index q denotes the
qth residue in peptide j. In our calculations, intrachain interactions will be
limited to the nonlocal residues i and j with ji – jjR 3, whereas interchain
interactions are defined between contact residues within neighboring
parallel and antiparallel peptides.
By following the same procedure we can calculate the variational free
energy for multiple chains. However, if all chains are identical, which is
valid in most applications, the fibril system can be assumed as a translational
invariant when the peptide number is large enough (M/N). Under that
condition, the constraints on each peptide are equal; so are the fluctuations
(so what we considered here is the uniformly collective modes for fluctua-
tions). The position correlation matrix GM and covariance matrix GM for
multiple peptides can be decomposed into the direct products of GS and
GS for a single peptide, i.e.,
GM ¼ IMM5GS (12)
andGM ¼ IMM5GS: (13)
This will lead to equations for variational energy E and entropy S similar to
S M S Mthat in Eqs. 8 and 9, except for replacing G by G , and G by G . With the
mean-field approximation, we can formulate a many-body problem into the
study of single peptides, which will greatly facilitate the research on real
amyloid fibers that may contain thousands of peptides.Determination of aggregation pathway
In the above sections, through the variational approach, we formulated the
problem of amyloid fiber formation into the study of a free energy func-
tional as a set of constraint parameters {C}. We especially focus on the
conformational transition between two distinguished states: one is a high
entropic denatured state with all {C} setting as zero (denoted as {CU}),
the other is the stable aggregated state with {C} corresponding to the lowest
free energy (denoted as {CN}). By continuously tuning the constraint
parameters from {CU} to {CN}, the fibrillation pathway (characterized by
the free energy surface) between the initial denatured state and the final
condensed state is completed constructed.Biophysical Journal 102(3) 597–605
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(equal to the length of peptide), an explicit exploration of all local minima
and saddle points seems almost impossible. In this study, to simplify the
calculation, we take a sequential search of the aggregation pathway on
the free-energy surface with the assumption that a residue (or residue
pair) can be either completely aggregated or not aggregated at all at each
aggregation step (in other words, a residue cannot be partially aggregated).
The explicit procedure is as follows. In Step 1, we identify the condensed
state ({C¼ CN}) with minimum free energy for the homogenous system. In
Step 2, we set tunable {C} for one residue (or residue pair) and {C¼ 0} for
the rest residues. Then choose the one with the lowest free energy barrier
height between {C ¼ 0} and {C ¼ CN} from all possible cases as the first
aggregation step. If there is no free energy barrier, as in the uphill or down-
hill cases, we take the free energy value at {CN}. In Step 3, we fix {C¼ CN}
for the residue (or residue pair) identified in Step 2, and repeat the proce-
dure in Step 2 for the rest residues until all of them are constrained at
{C ¼ CN}.RESULTS
Despite the generality of the constructed variational model
for multiple-chain aggregation, we will focus the applica-
tion on a small fibril assembly of the peptide GNNQQNY
from the yeast prion protein Sup35 whose structure was
recently solved (Fig. 1) (20). A systematic investigation
on this model system will help illustrate the detail procedure
of how to construct the free energy surface, how to identify
the most probable aggregation pathway, and how to deter-
mine the fibrillation temperature and the critical nucleus
size, etc. Although the short chain length of GNNQQNY
does not fulfill the Gaussian chain approximation that was
taken for the calculation of backbone potential, it has been
shown that the derivation is not large even when the chain
length is <10 (26,27). Our data of quantitative comparisons
with computational simulations and experimental data also
demonstrated that the Gaussian approximation should not
be a critical effect for the modeling of fibril aggregation,
and can be partly compensated by a choice of smaller
constraint parameters.FIGURE 3 Free energy surface for oligomers with size varying from one
to six peptides at T¼ 1. The constraint parameters {Ci} for each residue are
set equal.Parallel b-peptides are the major units
for GNNQQNY aggregation
The highly regular cross-b spine structure is generally re-
garded as the central part of amyloid fiber (20). However,
whether the parallel or antiparallel b-peptides make the
major contribution to the stability of fibril structure is still
controversial (23,28).
For the peptide GNNQQNY, we calculated the free
energy surface of single peptides and double parallel and
antiparallel b-peptides with homogeneous parameters
{Ci ¼ C} for all residues at T ¼ 1 (see Fig. 3), where Ci
represents the strength of the harmonic constraint put on
the ith residue in our variational model (see Eq. 6).
Clearly, the single GNNQQNY peptide favors the coil
structure at room temperature (29). For double peptides,
when the constraint parameter is small (C < 1.3), the freeBiophysical Journal 102(3) 597–605energy barrier for the parallel form is larger than the antipar-
allel, which means the initial formation of loose contacts
between antiparallel peptides is relatively easier and faster.
However, as the constraint gets strong enough, the free
energy for double antiparallel b-peptides becomes much
higher than the parallel (~8 kBT at C ¼ 2.9). Similar results
were also reported by molecular dynamic (MD) simulations
in that the parallel b-sheet is more stable than the antipar-
allel structure for the GNNQQNY dimer (28,30). Therefore,
we believe the parallel b-peptides make the major contribu-
tion to the stability of fibril structure.Asn2-Gln4-Asn6 provides a common folding core
for both parallel and antiparallel peptides
According to the search procedure we introduced in
Methods, we further examine the sequential folding
pathway for double parallel and antiparallel b-peptides by
varying the constraints on each residue pair separately. For
easy counting, we labeled two corresponding partner resi-
dues as 1–7, i.e., G1G1, N2N2, N3N3, Q4Q4, Q5Q5,
N6N6, and Y7Y7 for parallel peptides, and G1Y7, N2N6,
N3Q5, Q4Q4, Q5N3, N6N2, and Y7G1 for antiparallel
peptides.
A summary of our illustrated sequential folding pathways
for double parallel and antiparallel b-peptides is shown in
Fig. 4. Although the detailed sequential folding pathways
for double parallel and antiparallel b-peptides are not
exactly the same, they share some dramatic features in
common, i.e.:
1. The folding of both structures starts from the middle
residue pairing Q4Q4, which probably is a direct conse-
quence of the sequential symmetry of peptide
GNNQQNY in chemical nature.
2. Free energy barriers for central residue pairs (NNQQN)
are very small in both cases, so that the formation of
Amyloid Aggregation Pathway 601the central complementary structure is a highly coopera-
tive process in dynamics, and the sequence Asn2-Gln4-
Asn6 may serve as a common folding core for both
parallel and antiparallel b-sheets (21).
3. Edge residue pairs form at last (31,32).
The dominant importance of sequence N2-Q4-N6 for
GNNQQNY fibrillation uncovered by our variational model
is consistent with the all-atom MD simulations (22,33) and
experimental observations (20). These have showed that the
dry polar steric zipper structure through van der Waals inter-
actions between complementary side chains provides
a major contribution to stabilize the antiparallel b-sheet,
whereas the interstrand hydrogen bonds and aromatic stack-
ing are the driving forces to associate parallel b-sheet in an
in-register fashion.
This pathway result is consistent with the recent atomic
simulation for the parallel GNNQQNY dimer by Reddy
et al. (24). The authors showed that the folding of N2N2
and N3N3 residue pairs happens at almost the same time,
whereas the contact between N7N7 forms much later. This
is consistent with our result. However, as no direct trajectory
for the Q4Q4 residue pair was provided by the author, the
role of the stacking of Glu4 still requires further clarifica-
tion. The late formation of edge residue pairs could also
be learned from the different interaction energy of residue
pairs (29). The calculation in parallel peptides showed that
the interaction energies for edge residue pairs G1G1 and
Y7Y7 increase as two peptides move closer, whereas the
interaction energies decrease for other central residue pairs.
Thus, the formation of central residue pairs should be muchFIGURE 4 Sequential aggregation pathways are plotted through the
free energy surface (dashed lines) versus number of aggregated residue
pairs at T ¼ 1. (A) Aggregation pathway for double parallel peptides as
4-2-3-5-6-7-1. (B) Aggregation pathway for double antiparallel peptides
as 4-6-2-3-5-1-7. (C) Illustration of sequential aggregation pathways.
(Dashed lines) Newly formed aggregated residue pairs; (solid lines) previ-
ously formed aggregated residue pairs.easier than edge residue pairs. Further evidence comes from
the calculation of root mean-square position fluctuations of
Ca atoms. As shown in Fig. 5, the position fluctuations of
edge residues Gly1 and Tyr7 are much larger than central
residues under the same constraint parameters, which
were attributed to the þ1 and 1 charges associated with
them (24). The low fluctuations in the middle indicate that
much of the stability of the dimer is provided when the
hydrogen bonds formed between the two strands at the
central residues.Critical nucleus size for GNNQQNY
aggregation is 3
To interpret the aggregation mechanism of amyloid fiber,
classical nucleation theory was often borrowed (5,28,29),
which suggested that the formation of amyloid fiber starts
with an initial energetically unfavorable nucleation process,
with free monomers aggregated homogeneously or hetero-
geneously into some nuclei. Once these nuclei reach certain
critical size, they can spontaneously grow into long mature
fibrils by sequential monomer addition at both ends, which
is usually referred as the ‘‘elongation process’’ (30). Thus,
the critical nucleus size serves as an important quantity to
characterize the nucleation stage, and is directly related to
the intrinsic chemical nature of amyloid proteins and the
fibrillation conditions.
To explore this problem, we first studied the homoge-
neous nucleation process of 1–6 peptides with equal
constraint parameters {Ci ¼ C} on all residues at T ¼ 1
(see Fig. 3). As we can see, the free energy for the monomer
and dimer (either parallel or antiparallel) is always positive.
For the trimer, the free energy is negative only when
the constraint is very small, and it turns positive when
C > 1.2. For bigger oligomers with size >3, their free ener-
gies keep negative for reasonable constraint parameters
(C > 7.6). The corresponding minimum free energies for
different oligomers can be determined as F(N ¼ 3) ¼
3.19 kBT at C ¼ 0.3; F(N ¼ 4) ¼ 13.13 kBT atFIGURE 5 Root mean-square position fluctuations of backbone residues
in hexamer as a function of constraint parameters.
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602 Qi et al.C¼ 1.8; F(N¼ 5)¼28.51 kBTat C¼ 2.5; and F(N¼ 6)¼
44.60 kBT at C ¼ 2.9. Therefore we believe the trimer acts
as the critical nucleus in the homogeneous nucleation
process of GNNQQNY peptides. Similar conclusions have
also been reported by Nelson (20) and Zheng et al. (22).
The thermal stability of oligomers in different sizes could
be learned from the aggregation temperature (as illustrated
through the trimer in Fig. 6), which is defined as the point
at which the minimum free energy of the system equals to
zero. Below this temperature, the free energy of the
condensed state becomes negative, and the monomers can
spontaneously aggregate into oligomers. Through system-
atic exploration, we found the aggregation temperature
increases with oligomer size, i.e., T* ¼ 1.12 for trimer;
T* ¼ 1.27 for tetramer; T* ¼ 1.36 for pentamer; and
T* ¼ 1.43 for hexamer. Therefore, larger oligomers appear
more stable than smaller ones. The aggregation temperature
that we determined for the trimer system is close to the
results (T* ~ 1.2) obtained by Cecchini et al. (33) through
replica-exchange MD simulation, which corresponds to
the maximum fluctuations in the radius of gyration.
We further explored the sequential nucleation process of
the oligomers—a heterogeneous nucleation procedure
where peptides nucleate one by one in contrary to the homo-
geneous nucleation. Through the tree plot in Fig. 7, we listed
all possible sequential nucleation pathways for a hexamer
by simultaneously changing the constraints on single
peptides while keeping the rest of the peptides at the
condensed state (C ¼ 2.9 corresponding to the minimum
free energy in the homogenous system). Then the occur-
rence probability of the ith path is given by
Pi ¼
Q6
Step j¼ 1
Pij
P26
Path i¼ 1
 Q6
step j¼ 1
Pij
;
where Pijf exp(bDFij ), and DFij is the free energy barrier
height for step j in the path i. As we can see in Fig. 7, the firstFIGURE 6 Free energy surface for a trimer at different temperatures. The
constraint parameters {Ci} for each residue are set equal.
Biophysical Journal 102(3) 597–605three steps are critical for the heterogeneous nucleation. The
relative occurrence probabilities for the paths of S1-S3-S2,
S1-S3-S5, S1-S2-S3, S1-S3-S4, and S1-S2-S4 are
1:0.45:0.03:0.02:0.02. Thus, the zig-zag form (S1-S3-S2)
and the parallel-sheet form (S1-S3-S5) are the two most
favorable patterns for trimer formation. Similar results
were also observed by Zhang et al. (34) in MD simulations
that showed that new strands might prefer to extend in
a parallel arrangement to form oligomers. After critical
steps, the free energy surfaces for most paths become down-
hill. And the differences between each path are subtle. This
also helps us to reach a conclusion that the critical nucleus
size for GNNQQNY is 3.Aggregation of free monomer to fibril is a highly
cooperative process
To explore how fiber elongation spontaneously proceeds
after the nucleation stage, we constructed the aggregationFIGURE 7 Tree plot for all possible sequential nucleation patterns of
a hexamer. S1–S6 corresponds to the peptide number assigned in Fig. 2.
(Brackets) Values denote the free energy barrier heights (or the free energy
difference between the condensed state and the denatured state if the free
energy surface is downhill) at each nucleation step.
Amyloid Aggregation Pathway 603pathway for individual free peptides attaching onto existing
fibril. We took hexamer as a reference system, in which five
peptides are fixed at the condensed state with C ¼ 2.9 (cor-
responding to the minimum free energy in the homogenous
system), whereas the C values for residues in the sixth
peptide are freely tunable.
Through the calculated sequential aggregation pathway
(Fig. 8), an overall downhill free energy surface was
observed, which indicates that the process of monomer at-
taching onto the existing fibril is a highly cooperative
process. From Fig. 8, the initial attachments of residues
Gln4, Asn6, and Gly1 are relatively easy according to the
downhill free-energy surface, which is probably due to the
strong orientation force between hydrophilic residues
induced by existing fibril structures. Starting from the
contact of residue Asn2, the attachments of Asn3, Gln5,
and Tyr7 cause a slight increase in free energy, correspond-
ing to the optimization of b-strand registers (21). The final
stabilization of Tyr7 suggested that the p-p stacking of
aromatic residues plays an important role in stabilizing the
oligomer structure rather than giving directionality for
b-strand alignment (31,32,34).
The above analysis coincides with the general picture of
dock-and-lock mechanism proposed by Reddy et al. (35),
which suggests that fiber aggregation starts with a relatively
easy dock step and finishes in a more difficult lock proce-
dure of the remaining residues. However, in our model,
the docking starts from central hydrophilic residues (Gln4
and Asn6) based on the minimization of free energy;
whereas in Reddy’s simulations, they arbitrarily chose
Gly1 to start with (35).DISCUSSIONS
The focus of this work is on constructing a microscopic ther-
modynamic theory that can provide quantitative insights of
the amyloid fiber formation process only from the peptideFIGURE 8 Sequential aggregation pathway for a single free monomer
attaching to an existing pentamer, which is plotted through the free energy
surface (dashed line) versus the number of aggregated residues at T ¼ 1.
The residue aggregation order is shown as 4-6-1-2-3-5-7.sequence and the fiber crystal structure. Based on the
residue-level variational modeling approach, we performed
a systematic investigation of the aggregation pathways of
oligomers formed by peptide GNNQQNY from the yeast
prion protein Sup35. Our analytical results demonstrated
that: 1), the central dry polar zipper structure is the major
folding core for both double parallel and antiparallel
b-peptides; 2), trimer acts as the critical nucleus in the
homogeneous nucleation process of GNNQQNY peptides;
3), the heterogeneous nucleation prefers the zig-zag growth
pattern; and 4), the aggregation of free peptides to existing
fibrils is a highly cooperative process, consistent with the
dock-and-lock procedure.
Despite the generality of the theoretical framework and
detailed calculations of this work, there are several issues re-
maining to be addressed.
First, in dealing with the free energy calculation of fiber
systems, some approximations were taken to make the
model analytically treatable, such as the Gaussian chain
approximation for backbone potential, the pairwise contact
potential for intrachain and interchain interactions, and the
harmonic approximation for the native free energy surface
around the reference state. Thus our predicted free energy
surface can be shifted away from the real fibril systems.
Though our quantitative comparisons with the computa-
tional and experimental data demonstrate that these approx-
imations may not have a major impact on the effective
modeling of the fibrillation process, where many can be
partly compensated by the choice of different constraint
parameters, it is not clear to us to what extent these approx-
imations can robustly hold.
Second, the determination of most probable pathways for
fiber aggregation is a crucial step in our model application.
Due to the high dimensionality of the free energy surface, an
explicit exploration of all local minima and saddle points is
not possible. In this article, we adopted a sequential search
by assuming that each residue can only take two discrete
states (aggregated or not aggregated). In reality, those
partially aggregated states should be taken into consider-
ation for a comprehensive study. For this purpose, we
perform a completely different study based on the method
of free energy steepest descent, which searches the local
free energy minimum (rather than the minimal free energy
barrier in the sequential search) and allows the partial aggre-
gation of residues. The details are provided in the Support-
ing Material, which show that the basic predictions of two
different searching methods are in qualitative agreement.
However, a quantitative relationship between the exact
aggregation pathway and the one based on the on-or-off
mechanism is yet to be explored.
Third, in addition to the data we have provided, additional
quantitative comparisons with computational and experi-
mental studies could be performed, which include: 1), the
aggregation temperature for oligomers with different size,
2), root mean-square position fluctuations of residuesBiophysical Journal 102(3) 597–605
604 Qi et al.(or Ca atoms) in the fibril, and 3), aggregation order of resi-
dues in the fiber, etc. A critical test is concerned with the
elucidation of the amino-acid sequence dependence in
amyloid fibril formation. It is known that point mutations
on certain key residues can dramatically change the stabili-
ties of the fibril structures under physiological conditions.
For instance, the study by Abedini et al. (36) showed that
even a single point mutation can convert the highly amyloi-
dogenic human islet amyloid polypeptide into a potent
fibrilization inhibitor. The exploration of these issues would
significantly enhance the usefulness of our model and also
improve our understanding with a residue-level description
of the amyloid fibril systems. Related work is under
progress.SUPPORTING MATERIAL
Data and discussions of the free energy calculations based on the steepest
descent method are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(11)05467-1.
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